Influenza Vaccine Market: 2020 Worldwide Opportunities, Market Share, Key Players

The global influenza vaccines market size is slated to reach USD 7.34 billion by 2026, exhibiting a CAGR of 7.7% during the forecast period. Increasing prevalence of influenza worldwide will be the major driving force behind the growth of this market. According to the World Health Organization (WHO), around 3 to 5 million cases of influenza-based diseases are reported annually across the globe. This has spurred governments to take proactive measures to contain the spread of this deadly disease. Many governments carry out extensive vaccination drives before the flu season begins to immunize people from contracting any such infections, bolstering the seasonal influenza vaccines market demand. At the global level, organizations such as the WHO and the United Nations' Children Fund (UNICEF) regularly recommend various seasonal and general influenza vaccines to regional public authorities. These factors are expected to give rise to a robust growth period for this market.

The report provides market analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Key Features of Influenza Vaccine Market Report:
o Overview, Industry Life Cycle Analysis, Supply Chain Analysis
o Size, Trends, Growth Drivers, Constraints, SWOT Analysis, Forecast Analysis
o Competitive Landscapes: Market Share, Product Portfolio, New Product Launches, etc.
o Market attractiveness and Associated Growth Opportunities
o Strategic Growth Opportunities for the Existing and New Players
o Key Success Factors
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/influenza-vaccine-market-101896

North America to Occupy a Commanding Position; Asia-Pacific to Register Robust Growth
Having generated a revenue of USD 1.98 billion in 2018, North America is expected to dominate the influenza vaccines market share primarily owing to the utilization of advanced manufacturing systems and processes for vaccines. Besides this, rising incidence of influenza, well-funded vaccine research programs, and presence of big companies will further fuel the market in this region. Asia-Pacific will boast the highest growth rate among regions on account of fast-increasing population along with active government support for healthcare research will raise the demand for effective vaccines in the region. Lastly, increasing immunization rate, coupled with high awareness regarding vaccination, will drive the market in Europe.
Key Companies and Manufacturers Covered:
o AstraZeneca
o F. Hoffmann-La Roche Ltd
o Sanofi
o GlaxoSmithKline plc.
o Sinovac Biotech Ltd
o CSL Limited
o Emergent BioSolutions Inc.
o BioDiem

Presence of a Few Players to Make Competition Tight
Through its influenza vaccines market report, Fortune Business Insights(TM) has brought out an in-depth analysis of the competition in this market. The report states that the competitive landscape will be dotted by a few key players who are increasing their investment in enhancing their R&D capacities to widen their product portfolio.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/influenza-vaccine-market-101896

Detailed Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. New Product Launch
4.2. Pipeline Analysis
4.3. Prevalence of Influenza- For Key Countries, 2018
4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
5. Global Influenza Vaccines Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast - By Type
5.2.1. Inactivated
5.2.2. Live Attenuated
5.3. Market Analysis, Insights and Forecast - By Valency
5.3.1. Quadrivalent
5.3.2. Trivalent
5.4. Market Analysis, Insights and Forecast - By Age Group
5.4.1. Pediatric
5.4.2. Adults
5.5. Market Analysis, Insights and Forecast - By Distribution Channel
5.5.1. Hospital & Retail Pharmacies
5.5.2. Government Suppliers
5.5.3. Others
5.6. Market Analysis, Insights and Forecast - By Geography
5.6.1. North America
5.6.2. Europe
5.6.3. Asia pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
6. North America Influenza Vaccines Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast - By Type
6.2.1. Inactivated
6.2.2. Live Attenuated
6.3. Market Analysis, Insights and Forecast - By Valency
6.3.1. Quadrivalent
6.3.2. Trivalent
6.4. Market Analysis, Insights and Forecast - By Age Group
6.4.1. Pediatric
6.4.2. Adults
6.5. Market Analysis, Insights and Forecast - By Distribution Channel
6.5.1. Hospital & Retail Pharmacies
6.5.2. Government Suppliers
6.5.3. Others
6.6. Market Analysis, Insights and Forecast - By Country
6.6.1. U.S.
6.6.2. Canada
7. Europe Influenza Vaccines Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast - By Type
7.2.1. Inactivated
7.2.2. Live Attenuated
7.3. Market Analysis, Insights and Forecast - By Valency
7.3.1. Quadrivalent
7.3.2. Trivalent
7.4. Market Analysis, Insights and Forecast - By Age Group
7.4.1. Pediatric
7.4.2. Adults
7.5. Market Analysis, Insights and Forecast - By Distribution Channel
7.5.1. Hospital & Retail Pharmacies
7.5.2. Government Suppliers
7.5.3. Others
7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
7.6.1. U.K.
7.6.2. Germany
7.6.3. France
7.6.4. Spain
7.6.5. Italy
7.6.6. Scandinavia
7.6.7. Rest of Europe

Continued...

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.